These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38328918)

  • 1. Diastolic Dysfunction as a Positive Predictor of Recurrent Vascular Events in Patients With Noncardioembolic Stroke.
    Ishizuka K; Hoshino T; Mizuno T; Takahashi S; Wako S; Arai S; Toi S; Kitagawa K
    Stroke; 2024 Mar; 55(3):595-603. PubMed ID: 38328918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack.
    Hoshino T; Ishizuka K; Toi S; Mizuno T; Nishimura A; Takahashi S; Wako S; Kitagawa K
    Stroke; 2022 Jan; 53(1):79-86. PubMed ID: 34470483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study.
    Hoshino T; Mizuno T; Ishizuka K; Takahashi S; Arai S; Toi S; Kitagawa K
    Cardiovasc Diabetol; 2022 Nov; 21(1):264. PubMed ID: 36451149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of Hypertriglyceridemia in Patients With Stroke of Atherothrombotic Origin.
    Hoshino T; Ishizuka K; Toi S; Mizuno T; Nishimura A; Wako S; Takahashi S; Kitagawa K
    Neurology; 2022 Apr; 98(16):e1660-e1669. PubMed ID: 35296551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of circulating CD34+ cells level and prognosis after ischemic stroke.
    Mizuno T; Hoshino T; Ishizuka K; Toi S; Takahashi S; Wako S; Arai S; Kitagawa K
    Int J Stroke; 2024 Apr; 19(4):460-469. PubMed ID: 37978860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Bohula EA; Wiviott SD; Giugliano RP; Blazing MA; Park JG; Murphy SA; White JA; Mach F; Van de Werf F; Dalby AJ; White HD; Tershakovec AM; Cannon CP; Braunwald E
    Circulation; 2017 Dec; 136(25):2440-2450. PubMed ID: 28972004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognosis of left ventricular diastolic dysfunction in community hypertension patients.
    Zhou D; Yan M; Cheng Q; Feng X; Tang S; Feng Y
    BMC Cardiovasc Disord; 2022 Jun; 22(1):265. PubMed ID: 35698035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
    Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of left ventricular diastolic dysfunction in cryptogenic ischemic stroke.
    Seo JY; Lee KB; Lee JG; Kim JS; Roh H; Ahn MY; Park BW; Hyon MS
    Stroke; 2014 Sep; 45(9):2757-61. PubMed ID: 25074516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial.
    Gorelick PB; Richardson D; Kelly M; Ruland S; Hung E; Harris Y; Kittner S; Leurgans S;
    JAMA; 2003 Jun; 289(22):2947-57. PubMed ID: 12799402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Impact of the Cardio-Ankle Vascular Index for Predicting Cardiovascular Events After Acute Coronary Syndrome.
    Gohbara M; Iwahashi N; Sano Y; Akiyama E; Maejima N; Tsukahara K; Hibi K; Kosuge M; Ebina T; Umemura S; Kimura K
    Circ J; 2016 May; 80(6):1420-6. PubMed ID: 27116899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Kidney Dysfunction and Ischemic Stroke Outcomes: Albuminuria, but Not Estimated Glomerular Filtration Rate, Is Associated with the Risk of Further Vascular Events and Mortality after Stroke.
    Lee SJ; Lee DG
    PLoS One; 2016; 11(5):e0155939. PubMed ID: 27213281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of new vascular events with lifestyle intervention in patients with noncardioembolic mild ischemic stroke: a single-center randomized controlled trial.
    Kono Y; Yamada S; Yamaguchi J; Hagiwara Y; Iritani N; Ishida S; Araki A; Hasegawa Y; Sakakibara H; Koike Y
    Cerebrovasc Dis; 2013; 36(2):88-97. PubMed ID: 24029303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitation.
    Sander D; Weimar C; Bramlage P; Brandt T; Rosin L; Siebler M
    BMC Neurol; 2012 Sep; 12():102. PubMed ID: 23007013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation.
    Kumar P; Patel A; Mounsey JP; Chung EH; Schwartz JD; Pursell IW; Gehi AK
    Am J Cardiol; 2014 Aug; 114(3):407-11. PubMed ID: 24948489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Novel Score to Predict Left Ventricular Diastolic Dysfunction After Catheter Ablation of Nonparoxysmal Atrial Fibrillation With Preserved Ejection Fraction.
    Egami Y; Nohara H; Kawanami S; Sugae H; Ukita K; Kawamura A; Nakamura H; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Yano M; Nishino M; Tanouchi J
    Am J Cardiol; 2023 Aug; 200():128-134. PubMed ID: 37321025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease: Insights From the AFIRE Trial.
    Kaikita K; Yasuda S; Akao M; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e010476. PubMed ID: 34474583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
    Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Low Baseline Low-Density Lipoprotein Cholesterol on Long-Term Postdischarge Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.
    Cho KH; Kim MC; Choo EH; Choi IJ; Lee SN; Park MW; Park CS; Kim HY; Kim CJ; Sim DS; Kim JH; Hong YJ; Jeong MH; Chang K; Ahn Y
    J Am Heart Assoc; 2022 Sep; 11(17):e025958. PubMed ID: 36000434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.